296. 胆道閉鎖症 Biliary atresia Clinical trials / Disease details
臨床試験数 : 71 / 薬物数 : 70 - (DrugBank : 39) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 60
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ITMCTR2100005205 | 2019-04-01 | 2021-08-26 | Clinical Study of Lidan Mixture on Children with Biliary Atresia after Hilar Jejunal Anastomosis | Clinical Study of Lidan Mixture on Children with Biliary Atresia after Hilar Jejunal Anastomosis | Biliary atresia | Control group:Conventional antibiotics, ursodeoxycholic acid, hormones and Lidan Mixture;Therapy group:Conventional antibiotics, ursodeoxycholic acid, hormones; | Wuhan Children's Hospital | NULL | Recruiting | 0 | 1 | Male | Control group:30;Therapy group:30; | N/A | China |
| 2 | ChiCTR1800015250 | 2018-01-01 | 2018-03-19 | The Effect of Adjuvant UDCA Therapy Post-Kasai Portoenterostomy in Biliary Atresia: a multicenter randomized controlled trial | The Effect of Adjuvant UDCA Therapy Post-Kasai Portoenterostomy in Biliary Atresia: a multicenter randomized controlled trial | biliary atresia | high-dose:UDCA 25mg/kg po;low-dose:UDCA 15mg/kg po; | Children's Hospital of Fudan University | NULL | Recruiting | Both | high-dose:100;low-dose:100; | China |